A Note: Support groups listed are posted as a public service and are not managed by the ALF. Please check with the contact listed regarding meetings.
ANDERSON-NorCal Hepatitis C Network
Anderson, CA
Anderson, CA
Please call for more information and referrals
Contact Toni for more information.
Phone: 530-945-7853
Serving Amador, Tuolumne and Calaveras Counties:
ANGELS CAMP Sierra Hope Hepatitis Support Group
Angels Camp - (Directions)
1168 Booster Way
Angels Camp, CA 95222
Meets: 2nd and 4th Thursday 6:30-7:30
Contact Sami Rhodes for more information.
Phone: 209-736-6792
BAKERSFIELD: Hope for HCV
Bakersfield - (Directions)
5800 District Blvd, Suite 200
Bakersfield, CA 93313
Meets: Thursdays 12-1:00pm
Lunch is included.
Contact Debbie McGrath for more information.
Phone: 661-615-6000
CARSON CITY: Liver Transplant Support Group
Carson-Tahoe Hospital Health Education Center
Carson City, NV
Meets: Third Thursday of every month, 6-8PM
Contact Paul Saucedo for more information.
Phone: 775-883-3626
Web: www.thetransplantnetwork.com
CARSON CITY: Sierra-Nevada Hepatitis C Support Group
Contact Sandy Curl or Shawna Jones for more information.
Phone: 775-883-5415 (775-721-1468)
Email: CARSON CITY: Sierra-Nevada Hepatitis C Support Group
CHICO: Support Group & Educational Class
Butte Co/Chico & Oroville - (Directions)
Chico Family Health Center
680 Cohasset Rd
Butte Co/Chico & Oroville, CA 95928
Meets: 3rd Thursday of the month, 12:30-1:30 pm
Contact Jorge Escobar for more information.
Phone: 530-342-4395 ext.122
CHICO: Hepatitis C Support Group
North Valley Plaza Mall, Community Room - (Directions)
801 East Avenue
Chico, CA
Meets: Third Thursday of every month, 7-9PM
Contact Jorge Escobar for more information.
Phone: 530-342-4395 ext.122
CHICO: Hepatitis C Support Group
Enloe Conference Center, room 108 - (Directions)
5th and Esplanade
Chico, CA
Meets: First and third Thursday of every month, 6-7PM
Contact Pam Smallhouse for more information.
Phone: 530-891-0926
FREMONT: Tri City Health Center Hepatitis C Support Group
Tri City Health Center - (Directions)
39500 Liberty Street
Fremont, CA
Meets: Meets every other Friday
Contact Tisa Hall for more information.
Phone: 510-713-6690 x6151
GARBERVILLE: Living With Hepatitis C
California - (Directions)
464 Maple @Locust
Garberville, CA
Meets: Call for meeting times
Contact Beth Wells for more information.
Phone: (707) 923-2783 ext. 331
Email: GARBERVILLE: Living With Hepatitis C
HANFORD: Gift of Life Organ Transplant Support Group
Please contact Larry Peichoto for more information on individual support.
Contact Larry Peichoto for more information.
Phone: 559-584-7471
HANFORD: Hepatitis C Support Group Open to All, Spouses, Partners, Family Members
Hanford/ Kings County - (Directions)
Central Valley General Hospital
1025 N. Doughty St
Hanford/ Kings County, CA 93230
Meets: Last Sat Of Every Month, 11am-1pm 6/28, 7/26, 8/30, 9/27, 10/25, 11/29, 12/27
Contact Robert Katz or Liz Alvarez for more information.
Phone: 559-562-3139 or 559-625-1811
Email: HANFORD: Hepatitis C Support Group Open to All, Spouses, Partners, Family Members
HANFORD: Hepatitis C Support Group
Hanford, California - (Directions)
Central Valley General Hospital
1025 N. Doughty Street
Hanford, CA 93230
Meets: Every Last Saturday 11am to 1pm (7/26, 8/30, 9/27, 10/26, 11/29, 12/27),
Contact Robert Katz for more information.
Phone: 559-562-3139
HAYWARD: Kaiser Hepatitis C Support Group
Hayward Kaiser, Conference Room C-1 - (Directions)
27400 Hesperian Blvd.
Hayward, CA
Meets: Third Wednesday of every month, 7-8:30 PM
Contact Karen Forte, RN for more information.
Phone: 510-784-6695
LAKE FOREST: Saddleback Church
Saddleback Church - (Directions)
1 Saddleback Pkwy
Lake Forest, CA 92630
Meets: 3rd Thursday Of The Month 6:30-8:30pm
Contact Elaine for more information.
Phone: 949-609-8392
LAS VEGAS: Hepatitis C Support Group
Community Counseling Center - (Directions)
1120 Almond Tree Lane
Las Vegas, NV 89104
Meets: Meets every Tuesday, 5:30 PM
Contact Bob Barone for more information.
Phone: 702-369-8700
Email: LAS VEGAS: Hepatitis C Support Group
LAS VEGAS: Hepatitis C Support Group Sponsored by Mister Greengenes Nutrition Center & Juice Bar
Von's Shopping Center - (Directions)
3315 E. Russell Rd., #A3 (Russell Rd. at Pecos)
Las Vegas, NV 89120
Meets: Third Wednesday of every month, 7-9 PM
Contact Charles for more information.
Phone: 702-450-2100
Email: LAS VEGAS: Hepatitis C Support Group Sponsored by Mister Greengenes Nutrition Center & Juice Bar
LAS VEGAS: People Helping People
Las Vegas, Nevada - (Directions)
1120 Almond Tree Lane Ste 207
Las Vegas, NV 89109
Contact Bob Barone for more information.
Phone: 702-369-8700
Email: LAS VEGAS: People Helping People
MANTECA: Hepatitis C Support Group
Manteca Valley Community Counseling & Doctors Hospital - (Directions)
1205 E. North St.
Conference Room
Manteca, CA
Meets: First Wednesday of every month, 7-9 PM
Contact Gene & Rose Medford for more information.
Phone: 209-823-2172
Email: MANTECA: Hepatitis C Support Group
MARYSVILLE: Hepatitis C Support Group
- (Directions)
F.O.R. Families
5370 Packard Avenue #100
Marysville, CA
Meets: Meets every Thursday, 12 PM
Contact Melinda Borja for more information.
Phone: 530-671-7441
Email: MARYSVILLE: Hepatitis C Support Group
MENLO PARK: Hepatitis C Support Group for Veterans
VA Menlo Park, Mental Health Clinic - (Directions)
795 Willow Road
Room B112
Menlo Park, CA
Meets: Meets last Wednesday of every month, 1:30-2:30 PM
Contact Rosemary Geiser, RN for more information.
Phone: 650-493-5000 x27330
MODESTO: Greater Modesto Liver Disease Support Group
City Mall Building - (Directions)
948 11th Street
Room 20-23
Modesto, CA
Meets: Meets every Thursday, 7 PM
Contact Liz Poulsen for more information.
Phone: 209-579-1151
Email: MODESTO: Greater Modesto Liver Disease Support Group
NEVADA COUNTY: Hepatitis C Support Group
Sierra Nevada Memorial Hospital
Nevada City, CA
Contact Kathy Thomas for more information.
Phone: 530-265-2317
OAKLAND-Mandana Hepatitis C Support Group
Oakland, CA - (Directions)
3989 Howe St
Oakland, CA 94611
Meets: 1st and 3rd Monday of the month, 7-8 PM
Phone: 510-595-9690 (510-595-9660)
Alameda County +:
OAKLAND: Hepatitis C Support Group
O.A.S.I.S. Clinic - (Directions)
520 27th Street Oakland
Oakland, CA 94612
Meets: Meets every Monday and Wednesday at Noon
Arrive before noon. Lunch provided
Phone: 510-496-0189
Web: www.oasisclinic.org
Email: OAKLAND: Hepatitis C Support Group
OAKLAND: HEPPAC, HCV Support Group
- (Directions)
5323 Foothill Boulevard
Oakland, CA 94601
Meets: Meets every other Friday, Noon-2 PM
Contact Donna Hatch for more information.
Phone: 510-434-0307 x308
OAKLAND: I Will Survive Hep C Support Group
Mandana House - (Directions)
3989 Howe Street (Entrance on 40th St. Way)
Oakland, CA
Meets: First and third Monday of every month, 7-8:30 PM
Contact Peggy Moore for more information.
Email: OAKLAND: I Will Survive Hep C Support Group
ON-LINE: Acute Liver Failure Support Group
Meets: Quarterly and by phone/email
Through the American Liver Foundation we are a circle of individuals who provide personal connection and information to those who have experienced a liver transplant through acute liver failure.
Contact Jodi Takahashi (American Liver Foundation) for more information.
Phone: 925-580-5336 (800.292.9099)
Email: ON-LINE: Acute Liver Failure Support Group
ON-LINE: Liverfamilies.net (Parents of Children)
On-line support group for parents
Web: www.liverfamilies.net
OROVILLE: Hepatitis C Support Group
Oroville Family Health Center - (Directions)
2800 Lincoln Blvd.
Oroville, CA 95966
Meets: 2nd Tuesday of the month, 12-1 pm
This group meets on the third Wednesday of each month from 2 p.m. until 3 p.m. For more information, please contact Nancy at (530) 538-2889.
Contact Jorge Escobar for more information.
Phone: 530-342-4395
OROVILLE: Hepatitis C Community Class
California - (Directions)
2800 Lincoln Blvd
Oroville, CA 95966
Meets: 3rd Wednesday Of Every Month 2-3 PM
Contact Jorge Escobar for more information.
Phone: (530) 538-2889
PALO ALTO: Hepatitis C Support Group- Palo Alto
VA Palo Alto, Nutritional Conference Room - (Directions)
Building 100
3801 Miranda Avenue
Palo Alto, CA
Meets: Meets at varying times
Contact Barbara Cunningham, RN for more information.
Phone: 650-493-5000 x65898
PLACERVILLE: Hepatitis C Support Group
- (Directions)
6570 Pleasant Valley Road
Placerville, CA
Meets: Second Friday of every month, Noon-2 PM
Contact Katie for more information.
Phone: 530-621-2824
Email: PLACERVILLE: Hepatitis C Support Group
PLUMAS: Support Group & Educational Class
Plumas Co/Quincy, California - (Directions)
Plumas District Hospital Conference Room
1065 Bucks Lake Rd
Plumas Co/Quincy, CA 95971
Meets: 3rd Monday Of Each Month/Class At 2:00, Group At 3:00
Contact Melinda for more information.
Phone: (530)713-0090
PORTERVILLE: Hepatitis C Support Group
Porterville California - (Directions)
Sierra View District Hospital
465 W. Putnum Ave
Porterville, CA
Meets: Every 3rd Saturday 10am - 12pm
Contact Robert Katz or Liz Alvarez for more information.
Phone: 559-562-3139 (559-625-1811)
Email: PORTERVILLE: Hepatitis C Support Group
REDDING: Liver For Life Support Group
Redding Jet Center - (Directions)
3775 Flight Avenue
Redding, CA
Meets: Meets every Tuesday, 6:30-8 PM
Contact Teresa for more information.
Phone: 530-378-1686
REDDING: Planned Parenthood Hepatitis C Support Group
Planned Parenthood - (Directions)
2935 Bechelli Lane, Suite A
Redding, CA 96002
Meets: Third Tuesday of every month, 6-8 pm
Contact Toni Donovan for more information.
Phone: 530-945-7853
REDWOOD CITY: Hepatitis C Support Group
Sequoia Hospital Health and Wellness Services - (Directions)
Call for Location
Redwood City, CA
Meets: Meets third Thursday of every month, 7-8:30 PM
Contact Ginny Morrow, ANP for more information.
Phone: 650-367-5998
RENO: Liver Transplant Support Group
United Blood Services - (Directions)
1125 Terminal Way
Reno, NV
Meets: Meets first Wednesday of every month, 6:30-8 PM
Phone: 775-324-4501
Web: www.thetransplantnetwork.com
RENO: NASH Support Group
Contact Kari Conway for more information.
Phone: 775-857-0273
Email: RENO: NASH Support Group
RENO: Hepatitis C Support Group
Arlington Clinical - (Directions)
6630 South McCarran
Suite B14
Reno, NV
Meets: Meets 3rd Wednesday of every month, 7 PM
Contact Diana Howard, RN for more information.
Phone: 775-828-8200 x275
Email: RENO: Hepatitis C Support Group
SACRAMENTO: Hepatitis C Support Group
Sacramento Native American Health Center - (Directions)
2020 J Street
1st Floor
Sacramento, CA
Meets: Meets every Wednesday, 6-7 PM
Use phone number listed to get information about other support groups and clinics in the Sacramento area.
Contact Leslie Benson for more information.
Phone: 916-760-7426
Email: SACRAMENTO: Hepatitis C Support Group
SACRAMENTO: Liver Transplant Support Group
Sutter Roseville, Medical Center, - (Directions)
1 Medical Plaza Dr.
Conference Center A, 2nd Floor
Sacramento, CA
Meets: Meets second Sunday of every month, 2-4:30 PM
Contact Ann Linnekens for more information.
Phone: 916-791-1697
Web: www.saclivertxgroup.com
Email: SACRAMENTO: Liver Transplant Support Group
SACRAMENTO: PSC Support California
Sacramento or TBD Bay Area location
Sacramento, CA
Meets: Meets first Saturday of every other month, 2-4 PM
Contact Jennifer Soloway for more information.
Phone: 916-447-2221
Email: SACRAMENTO: PSC Support California
SAN FRANCISCO: Hepnada
San Francisco, California - (Directions)
San Francisco General Hospital Medical Center - Building 80
995 Potrero Ave. 6th Floor
San Francisco, CA 94110
Meets: Every Tuesday 5:00-6:30pm
Contact Val Robb, RN for more information.
Phone: 415.206.4370 (415.974.4370)
Email: SAN FRANCISCO: Hepnada
SAN FRANCISCO: Liver Disease Support Group
SFVA Medical Center - (Directions)
4150 Clement St. at 42nd Ave.,
Bldg. 200, Room 122 (Teak Room)
San Francisco, CA
Meets: Meets first Wednesday of every month. 6:30 PM
Contact Marian Kerbleski, RN for more information.
Phone: 415-221-4810 x3759
Email: SAN FRANCISCO: Liver Disease Support Group
SAN FRANCISCO: Liver Transplant Support Group
California Pacific Medical Center - (Directions)
2351 Clay St.
3rd Floor, Boardroom
San Francisco, CA
Meets: Meets every Monday and Thursday, 10-11:30 AM
Contact Marjorie Davis for more information.
Phone: 415-600-1035
Email: SAN FRANCISCO: Liver Transplant Support Group
SAN FRANCISCO: Living with Hepatitis C
Quan Yin Healing Arts Center - (Directions)
455 Valencia Street
San Francisco, CA 94103
Meets: First and Third Thursdays of each month
The support group will be held on the first and third Thursdays of each month at Quan Yin Healing Arts Center located in Mission district in San Francisco. This group is free and is geared toward people living with HCV. The support group will start at 6:45pm with light snack and will end at 7:45 pm. Mark Sorensen is an RN at CPMC Hepatology / Liver Transplant programs, working as an Hepatology Nurse Coordinator. He had previously worked for the City and County Community Health Network as a Hepatitis C treatment nurse for many years. Mark has vast knowledge on Hepatitis C treatment and a deep understanding of issues, not only treatment needs but also psychological, emotional, and social needs, among people living with HCV.
Contact Mark Sorenson, RN (CPMC Hepatology Nurse Coordinator) for more information.
Phone: 415-861-4964
Web: www.qyhac.org
Email: SAN FRANCISCO: Living with Hepatitis C
SAN FRANCISCO: Quan Yin HCV support group
Quan Yin Healing Arts - (Directions)
455 Valenica Street
San Francisco, CA
Contact Mark Sorensen for more information.
Phone: 415-861-4964
Email: SAN FRANCISCO: Quan Yin HCV support group
SAN FRANCISCO: Shanti L.I.F.E. HIV/HCV Co-Infection Drop-In Group
San Francisco - (Directions)
St. Mary's Medical Center
2235 Hayes, 4th floor
San Francisco, CA 94117
Meets: 3:00-4:45 pm Every Thursday
Contact Karl Knapper for more information.
Phone: 415-674-4706
Web: http://www.shanti.org/life/hivhcv.html
Email: SAN FRANCISCO: Shanti L.I.F.E. HIV/HCV Co-Infection Drop-In Group
SAN FRANCISCO: UCSF Liver Transplant Program Support Group
UCSF Medical Center - (Directions)
505 Parnassus, Long Solarium
San Francisco, CA
Meets: Meets Every Tuesday, 1-2 PM
Contact Sherry Laemmermanns, RN for more information.
Phone: 415-353-1040
Email: SAN FRANCISCO: UCSF Liver Transplant Program Support Group
SAN FRANCISCO: California Pacific Medical Center HCV Support Group
California Pacific Medical Center - (Directions)
2333 Buchanan St., 2nd Floor, Room 2424
Pathology Conference Room (enter at "Pathology and Clinical Laboratory" door)
San Francisco, CA
Meets: 1st and 3rd Tuesdays each month, 6:45 PM
The group is open to patients with hepatitis C, their family members and friends.
Contact Bill at 415-385-7180, Shirley at 415-664-7333 for more information.
Email: SAN FRANCISCO: California Pacific Medical Center HCV Support Group
SAN FRANCISCO: Hepatitis C Coinfection Issues
SFVA Medical Center - (Directions)
4150 Clement St. at 42nd Ave.,
Bldg. 203; Ib-26A
San Francisco, CA
Meets: Meets 4th Tuesday each month, 12 noon
Contact Marian Kerbleski, RN for more information.
Phone: 415-221-4810 x3759
Email: SAN FRANCISCO: Hepatitis C Coinfection Issues
SAN JOSE: Hepatitis C Support Group of Santa Clara County
St. Francis Episcopal Church - (Directions)
Newport and Pine Streets
Wickham Room
San Jose, CA 95125
Meets: Meets second and fourth Sunday of every month, 3-5 PM
Directions: http://www.stfrancisepiscopalchurch.org/WhereWeAre.html
Contact Susi Nielson for more information.
Phone: 408-734-3516
Email: SAN JOSE: Hepatitis C Support Group of Santa Clara County
SAN RAFAEL: Marin Hepatitis & Liver Disease Support Group
San Rafael, CA - (Directions)
101 Lucas Valley Road
San Rafael, CA 94903
Meets: Every Third Thursday of Each Month, 6:30 PM - 8:00 PM
Contact Bill Remak for more information.
Phone: 707-364-1802
Email: SAN RAFAEL: Marin Hepatitis & Liver Disease Support Group
SANTA CRUZ: HELP! Help and Education for Liver Patients
Santa Cruz Bible Church - (Directions)
440 Frederick Street
Room WC10
Santa Cruz, CA
Meets: Meets third Monday of every month, 6:30-8:30 PM
Materials & refreshments provided.
Contact C.N. Gordon for more information.
Phone: 831-462-2979
Web: www.santacruzpl.org/cid/public/full.php?id=341
Email: SANTA CRUZ: HELP! Help and Education for Liver Patients
SANTA CRUZ: HELP! Support-Persons Support Group
Jeffery’s Restaurant - (Directions)
2050 Soquel Avenue
Santa Cruz, CA
Meets: Meets the 2ndMonday of most months (call or email ahead for schedule), 6-8 PM
Contact C.N. Gordon for more information.
Phone: 831-462-2979
Email: SANTA CRUZ: HELP! Support-Persons Support Group
SANTA ROSA: Hepatitis C Support Group
Drug Abuse Alternatives Center - (Directions)
2403 Professional Dr.
Ste 101
Santa Rosa, CA
Meets: Meets 2nd and 4th Tuesday, 4-5:30 PM
Contact Lorie Violette for more information.
Phone: 707-548-0140
Email: SANTA ROSA: Hepatitis C Support Group
SANTA ROSA: Hepatitis C Support Group
Northern California Center for Well-Being - (Directions)
365 B Tesconi Circle
Santa Rosa, CA
Meets: Meets second Sunday of every month, 4 -6 PM
Contact Kate Wilcox for more information.
Phone: 707-575-6043
Email: SANTA ROSA: Hepatitis C Support Group
SEASIDE: Hepatitis C Support Group
VA Monterey - (Directions)
3401 Engineer Lane
Dermatology Conference Room
Seaside, CA
Meets: Meets first Friday of every month, 9:30-10:30 AM
Contact Janis Marquez, RN for more information.
Phone: 831-883-3820
SONOMA VALLEY: Hepatitis C Support Group
Sonoma Valley Hospital - (Directions)
347 Andrieux Street
Central Conference Room
Sonoma Valley, CA
Meets: Meets first Thursday of the month, 7-9 PM
Contact Tony Costa for more information.
Phone: 707-938-5101
Email: SONOMA VALLEY: Hepatitis C Support Group
SOUTH BAY, NORTH BAY, MODESTO: PBC & PSC Support Groups
Rotating Locations, South Bay; North Bay; Modesto
Meets: Meets every 3 months, 1-4 PM
Contact Barbara Pasek Brown (American Liver Foundation) for more information.
Phone: 650-968-9861
Email: SOUTH BAY, NORTH BAY, MODESTO: PBC & PSC Support Groups
SOUTH LAKE TAHOE-People Helping People-Hepatitis Support Group
South Lake Tahoe, CA - (Directions)
Barton Memorial Hospital Board Room
2170 South Avenue
South Lake Tahoe, CA 96150
Meets: 2nd Thursday 6-8 PM
Alternate Contacts: Rick 530-541-6074; Ken 530-577-3111
Contact John for more information.
Phone: 530-577-1412
STANFORD: Adult Liver Transplant Support Group
900 Blake Wilbur Builidng 1st Floor conference room
Stanford, CA 94305
Meets: every Monday 10:30-12:00
Only for Stanford patients
Contact Jenny Kwak, MSW, LCSW for more information.
Phone: 650) 498-5831
Email: STANFORD: Adult Liver Transplant Support Group
TUOLUMNE: Hepatitis C Support Group
Tuolomne General Hospital - (Directions)
101 Hospital Road, Sonora
Adult Day Health Care Center
Tuolumne, CA
Meets: Meets third Tuesday of every month, 6-7:30 PM
Contact Tina Dutra for more information.
Phone: 209-533-7229
Web: www.tghospital.com
Email: TUOLUMNE: Hepatitis C Support Group
UKIAH: Hepatitis C Support Group
- (Directions)
148 Clara Ave
Ukiah, CA
Meets: First and third Tuesdays of every month, 6:30-8:00 PM
Contact Carol Coronius for more information.
Phone: 707-462-1932
UKIAH: Hepatitis C Support Group
Mendocino County AIDS Volunteer Network - (Directions)
148 Clara
Ukiah, CA
Meets: Meets 1st and 3rd Tuesdays of every month 5:30-7 pm, 6:30 - 8 PM in winter
Contact Libby for more information.
Phone: 707-462-1932 ext. 205
Email: UKIAH: Hepatitis C Support Group
VACAVILLE: Liver Disease Support Group
Contact Larry Ricketts for more information.
Phone: 707-448-4912
VALLEJO: Hepatitis C/Liver Conditions Support Group
Kaiser Permanente - (Directions)
975 Sereno Drive
Solarium East
Vallejo, CA
Meets: Meets second Saturday of every month, 11 AM
Contact Chris Baker for more information.
Email: VALLEJO: Hepatitis C/Liver Conditions Support Group
VALLEJO: Liver Transplant Support Group
Kaiser Permanente - (Directions)
975 Sereno Drive
Conference Room 1 (confirm)
Vallejo, CA
Meets: Meets third Saturday of every month, 11-1 PM
Contact Glenn Andrus for more information.
Phone: 707-747-5725
Email: VALLEJO: Liver Transplant Support Group
VISALIA: Hepatitis C Support Group
Visalia, California - (Directions)
Visalia Health Center
2611 N. Dinuba Blvd
Visalia, CA 93291
Meets: 1st Saturday of the Month 10am to noon
Contact Robert Katz for more information.
Phone: 559-562-3139
WALNUT CREEK: Liver Support Group
John Muir Medical Center - (Directions)
1601 Ygnacio Valley Rd.
Sequoia 1 Room
Walnut Creek, CA 94598
Meets: Meets third Thursday of every month, 7-9 PM
Contact Katie McAdams for more information.
Phone: 925-820-4644
Email: WALNUT CREEK: Liver Support Group
WILLITS: Hepatitis C Support Group
Meets: Meets second and fourth Mondays of every month
Contact Elizabeth Ross for more information.
Phone: 707-463-5877
Email: WILLITS: Hepatitis C Support Group
YUBA CITY: Hepatitis C Support Group
The Church of Glad Tidings - (Directions)
Highway 99 and Eager Road
CE Building, Room #104
Yuba City, CA
Meets: Meets third Monday of every month, 7 PM
Phone: 530-671-7441
Acute Liver Failure-Multi-Center Trial to Study of Acute Liver Failure in Adults
University of California, San Francisco/ UC Davis
ALF has captured the interest and attention of researchers because of its unique pathogenesis and extreme severity, encouraging us to understand the processes underlying all forms of liver injury, by focusing on this most lethal manifestation.
The purpose of this study is to collect clinical and epidemiological data as well as serum, plasma, urine, tissue and DNA samples on individuals who have acute liver failure.
Inclusion Criteria:
Written Informed consent from patient's next of kin Altered mentation of any degree (encephalopathy) Evidence of moderately severe coagulopathy (INR ≥ 1.5) A presumed acute illness onset of less than 26 weeks The NIH guidelines on the inclusion of women and minorities as subjects in clinical research will be observed.Recruitment Period: Open
Principal Investigators:
UCSF: Timothy Davern, MD, Philip Rosenthal, MD
UCDavis: Lorenzo Rossaro, MD
Recruitment Period: OPEN
Phone: 415-514-2859
Acute Liver Failure-Study of Acute Liver Failure in Children
University of California, San Francisco
The proposal establishes a Pediatric Acute Liver Failure (PALF) Study Group to identify, characterize, and develop management strategies for infants, children and adolescents who present with acute liver failure. The PALF study group includes 19 sites (16 in the United States, 2 in the United Kingdom, and 1 in Canada).
Inclusion Criteria Include:
- <18 years old
- Meet entry criteria for and be enrolled in the Pediatric Acute Liver Failure prospective database.
- Able to be evaluated and initiate treatment within the first 24 hours of hospitalization
- Transfers from other hospitals okay, provided no liver support device (BAL, ELAD, transgenic pig perfusion) has been used or is contemplated.
Recruitment Period:
OPEN
Principal Investigator: Phillip Rosenthal, MD
Phone: 415-476-5892
Web: www.pediatrics.medschool.ucsf.edu/gi/research/studies/index.aspx
Alagille Syndrome-Study of Cholestatic Liver Diseases
University of California, San Francisco
Title: Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases
Participation in this study will last 5 years and will consist of a baseline visit and five annual follow-up visits. The study will enroll infants through adults 25 years of age who have, or are suspected of having, one of the four genetic cholestatic liver diseases. Individuals who are siblings of a-A1T and AGS participants and have underlying disease with no evidence of liver involvement may also be enrolled. Genetic testing will be performed using the collected specimens.
Inclusion Criteria:
- Meets criteria for or previously diagnosed with one of four cholestatic liver diseases: AGS, a-1AT, bile acid synthesis and metabolism defects, or PFIC
- Siblings of participant with AGS or a-1AT, who may themselves have the underlying disease but without liver involvement
- Literate in English
- Ability to complete an annual research visit at one of the participating Cholestatic Liver Disease Consortium (CLiC) centers
Recruitment Period: Open
Principal Investigator: Phillip Rosenthal, MD
Contacts: Danuta Filipowski, MD 415-476-1756, filipowski@peds.ucsf.edu & Shannon Flecks 415-476-1539, flecks@peds.ucsf.edu
Alchohol Induced Liver Disease: Effects of SAMe in Patients with Alcoholic Liver Disease
University of California, Davis
The purpose of the research is to establish profiles of methionine metabolites in blood samples and liver biopsy of patients with ALD and to demonstrate the metabolic rational and clinical efficacy of treatment of ALD patients with S-adenosylmethionin (SAMe).
Eligibility Criteria: Patients with active liver disease, abnormal liver functions tests, history of alcohol abuse, negative serology for heptatits B and C, Willingness to stop drinking for length of the study.
Recruitment Period: Open
Principal Investigator: Charles Halsted, MD
Contact Maria Catrina Virata for more information.
Phone: (916) 734-2670
Email: Alchohol Induced Liver Disease: Effects of SAMe in Patients with Alcoholic Liver Disease
Biliary Atresia: Biliary Atresia Study in Infants and Children
University of California, San Francisco
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. Most studies to date have focused on the neonate and young child with BA, yet the older surviving child with BA can provide important information about genetics, as well as, natural history.The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address hypotheses:
Inclusion Criteria:
- Confirmed diagnosis of BA determined by chart review
- Subjects need to be greater than or equal to one year of age (with no upper age limit).
- Subject either have their native liver or have a confirmed liver transplantation.
- Parent, guardian or subject (if 18 years of age or older) is willing to provide informed consent and, when appropriate, the subject is willing to assent.
Principal Investigator: Philip Rosenthal, MD
Recruitment Period: Open
Phone: 415-476-5892
Email: Biliary Atresia: Biliary Atresia Study in Infants and Children
Subjects with a known or suspected diagnosis of NAFLD, either simple steatosis, NASH or NASH-related cirrhosis or cryptogenic cirrhosis:
California Pacific Medical Center- Research Institute
Principal Investigator: Raphael Merriman, MD - (Directions)
2340 Clay Street
San Francisco, CA 94115
Protocol Title: Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2, as part of the NIH, NIDDK NASH (Nonalcoholic Steatohepatitis) Clinical Research Network study
Patient Population: Subjects with a known or suspected diagnosis of NAFLD, either simple steatosis, Nonalcoholic Steatohepatitis (NASH) or NASH-related cirrhosis or cryptogenic cirrhosis
Recruitment Period: Open
Contact Tony Nguyen (Clinical Research Coordinator) for more information.
Phone: 415-600-1544
Email: California Pacific Medical Center- Research Institute
Subjects with a known or suspected diagnosis of NAFLD, either simple steatosis, NASH or NASH-related cirrhosis or cryptogenic cirrhosis:
California Pacific Medical Center- Research Institute
Principal Investigator: Raphael Merriman, MD - (Directions)
2340 Clay Street
San Francisco, CA 94115
Protocol Title: MR Imaging and H1-MR Spectroscopy of the Liver in Non-alcoholic Steatohepatitis: Imaging-Histopathologic Correlation
Patient Population: Subjects with a known or suspected diagnosis of NAFLD, either simple steatosis, Nonalcoholic Steatohepatitis (NASH) or NASH-related cirrhosis or cryptogenic cirrhosis
Recruitment Period: Open
Contact Tony Nguyen (Clinical Research Coordinator) for more information.
Phone: 415-600-1544
Email: California Pacific Medical Center- Research Institute
Cixutumumab and Sorafenib Tosylate in Treating Patients with Advanced Liver Cancer
UC Davis Cancer Center
Description: This phase I trial is studying the side effects and best dose of cixutumumab when given together with sorafenib tosylate in treating patients with advanced liver cancer. Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving cixutumumab together with sorafenib tosylate may kill more tumor cells.
Inclusion Criteria: For inclusion criteria, please visit website listed.
Investigator: Robert T. O’Donnell, MD, PhD, UC Davis
Contact Corinne Turrell for more information.
Phone: 916-734-3089
Web: http://clinicaltrials.gov/ct2/show/NCT01008566?term=Liver+California&rank=4
Email: Cixutumumab and Sorafenib Tosylate in Treating Patients with Advanced Liver Cancer
ClinicalTrials.gov
A service of the U.S. National Insitutes of Health, ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. The information provided on ClinicalTrials.gov should be used in conjunction with advice from health care professionals.
Web: clinicaltrials.gov
Drug-Induced Liver Injury (DILN)Network Retrospective (ILIAD)
California Pacific Medical Center
Patient Population: Subjects 2 years or older diagnosed with ILIAD due to medications are isoniazid, phenytoin, clavulanic acid/amoxicillin, valproic acid, trimethoprim-sulfamethoxazole, minocycline and quinolone antibiotics. Subjects 2 years or older who took the same medications but did not develop ILIAD.
Principal Investigator: Timothy Davern, MD
Contact Katherine Fajardo for more information.
Phone: 415-600-1518
Web: http://www.cpmc.org/professionals/research/trials/heplisting.html
Email: Drug-Induced Liver Injury (DILN)Network Retrospective (ILIAD)
Drug-Induced Liver Injury Network (DILIN) Protocol #2- A Multicenter, Longitudinal Study of Drug-and CAM-Induced Liver Injury
California Pacific Medical Center
Patient Population: Subjects 2 years who have taken a drug complementary alternative medicine product and developed a liver reaction within the past 6 months.
Principal Investigator: Timothy Davern, MD
Contact Katherine Fajardo for more information.
Phone: 415-600-1518
Web: http://www.cpmc.org/professionals/research/trials/heplisting.html
Email: Drug-Induced Liver Injury Network (DILIN) Protocol #2- A Multicenter, Longitudinal Study of Drug-and CAM-Induced Liver Injury
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (SILVER)
California Pacific Medical Center
Patient Population: Subjects with acute decompensation of chronic liver disease (cirrhosis)
Principal Investigator: Dr. Todd Frederick
Contact Nina Topic, RN for more information.
Phone: 415-600-1721
Web: http://www.cpmc.org/professionals/research/trials/heplisting.html
Email: Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (SILVER)
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Subjects with Fulminant Hepatic Failure (FHF) (Vital Therapies 202)
California Pacific Medical Center
Patient Population: Subjects who are experiencing signs and symptoms of fulminant hepatic failure (FHF).
Principal Investigator: Dr. Todd Frederick
THIS STUDY HAS NOT YET OPENED FOR ENROLLMENT, BUT IS COMING SOON
Contact Nina Topic, RN for more information.
Phone: 415-600-1721
Web: http://www.cpmc.org/professionals/research/trials/heplisting.html
Email: Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Subjects with Fulminant Hepatic Failure (FHF) (Vital Therapies 202)
Fatty Liver Disease-Effects of Exenatide on Liver Biochemistry, Liver Histology and Lipid Metabolism In Patients With Fatty Liver Disease
University of California, Davis
Principal Investigator: Lars Berglund, MD, PhD; Christopher Bowlus, MD
Recruitment Period: Open
Contact Marilyn Robinson for more information.
Phone: 916-703-5501
Email: Fatty Liver Disease-Effects of Exenatide on Liver Biochemistry, Liver Histology and Lipid Metabolism In Patients With Fatty Liver Disease
Feasibility of Using Real-time Cine-MRI for Treating Moving and Deforming Tumors
Stanford University School of Medicine
Description: This study aims to investigate and optimize imaging sequences and parameters of rapid real-time MRI in order to obtain adequate guidance for accurately and precisely delivering radiation to moving abdominal and thoracic tumors
Inclusion Criteria: For inclusion criteria, please visit website listed.
Investigators: Paul Keall, Albert Koong, Dr. Billy W. Loo Jr. MD PhD, Kim Butts Pauly PhD, Amit Sawant, Shreyas Vasanawala
Contact Melody Chung for more information.
Phone: 650-736-0798
Web: http://med.stanford.edu/clinicaltrials/publicCancerDisplayDetails.do?studyId=2702&age=adul
Email: Feasibility of Using Real-time Cine-MRI for Treating Moving and Deforming Tumors
Genetic Analysis of Liver Cancer
Stanford University Medical Center
Description: Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of liver cancer influences clinical outcome and treatment response. We are developing a translational research program that will characterize molecular changes in liver cancer. We plan to use molecular information obtained from studying liver tumor tissues to develop new diagnostics and treatment regimens for patients with these cancers. The experimental approach will require freezing fresh tumor tissues obtained from surgical procedures, which will be subsequently used for analysis of DNA, protein and mRNA expression. Many patients with liver cancer are referred to the Stanford Liver Tumor Board for consultation and treatment recommendations. We propose to gather tissue samples from those who subsequently undergo biopsy, liver resection surgery or transplant surgery.
Inclusion Criteria: For inclusion criteria, please visit the website listed.
Investigators: Samuel So, Mei-Sze Chua
Contact Mei-Sze Chua for more information.
Phone: 650-724-3525
Web: http://med.stanford.edu/clinicaltrials/publicCancerDisplayDetails.do?studyId=1182&age=adul
Email: Genetic Analysis of Liver Cancer
Hepatitis B-A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1
University of California, San Francisco
Title: A Randomized Trial of Vaccine Adherence in Young IDU
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
Recruitment Period: Open
Principal Investigator: Paula Lum, MD, MPH
Phone: (415) 597-9100
Hepatitis B-Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
California Pacific Medical Center
San Francisco, CA
This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) vs. adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for 96 weeks after the last subject is randomized.
Principle Investigator: Dr. Ed Wakil
Recruitment Period: This study is ongoing, but not recruiting participants.
Contact Alex Rvykin, RN for more information.
Phone: 415-600-1158
Hepatitis B-Decompensated Liver Disease and the Prevention of Hepatitis B Reoccurence Post-Transplantation
California Pacific Medical Center - (Directions)
2324 Sacramento Street
San Francisco, CA
Protocol Title:
A Phase 2, Double-Blind, Multi-Center, Randomized Study Comparing Tenofovir Disoproxil Fumarate, and Entecavir in the treatment of Chronic Hepatitis B Subjects with Decompensated Liver Disease and in the Prevention of Hepatitis B Recurrence Post-Transplantation.
Patient Population:
Chronic Hepatitis B; decompensated. No recent GI bleed.
Recruitment Period:
ONGOING BUT NOT RECRUITING
Principal Investigator:
Dr. Robert Gish
Contact Allison Gilchrist, RN for more information.
Phone: 415-600-1768
Hepatitis B-Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
San Jose Gastroenterology
Title: A Comparative Study of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy vs. Entecavir Monotherapy in Adults Who Are Treatment-Naive to Nucleosides and Nucleotides: The BE-LOW Study
Principal Investigator: Huy Ngoc Trinh, MD
Recruitment Period: This study is ongoing, but not recruiting participants.
Phone: 408-347-9001
Greater Bay Area:
Hepatitis B-Quest Women's Clinic
San Francisco - (Directions)
2300 Sutter Street
Suite 208
San Francisco, CA 94115
Hepatitis B positive volunteers are needed to participate in a ninety-six week research study involving an investigational hepatitis B medication.
Participants will be compensated.
You may be eligible if you have:
- Chronic infection with hepatitis B.
- No prior treatment for hepatitis B.
- Otherwise good health; HIV negative.
If you qualify, please contact Quest Clinical Research at 415-353-0800.
Contact Dr. Jacob Lalezari (Quest Clinical) for more information.
Phone: 415-353-0212 (415.353.0800)
Web: http://www.questclinical.com/cshepb.html
Email: Hepatitis B-Quest Women's Clinic
Hepatitis B-Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Kaiser Permanente (Site 321)
Recruitment period: OPEN
Contact Walford Fessel for more information.
Email: Hepatitis B-Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Hepatitis B-Truvada Versus Truvada Plus HBIG in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant
Title: A Phase 2, Open-Label Randomized Study to Evaluate the Efficacy and Safety of the Combination Product, Emtricitabine/Tenofovir Disoproxil Fumarate in the Presence or Absence of Hepatitis B Immunoglobulin (HBIG) in Preventing Recurrence of Chronic Hepatitis B (CHB) Post-Orthotopic Liver Transplant (OLT)
ONGOING BUT NOT RECRUITING
Contact Jane Anderson, Ph.D for more information.
Email: Hepatitis B-Truvada Versus Truvada Plus HBIG in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant
Hepatitis B: A 96 Week Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B
Title: A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus the Combination of Emtricitabine and Tenofovir DF for the Treatment of Chronic Hepatitis B.
ClinicalTrials.gov identifier: NCT00507507
This study is ongoing, but is not recruiting participants.
Contact Jane Anderson, PhD for more information.
Email: Hepatitis B: A 96 Week Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B
Hepatitis C-Gradual Withdrawal of Immune System Supressing Drugs in Patients Receiving a Liver Transplant
San Francisco, CA
Principal Investigator-Sandy Feng, MD
Contact Sharon Blaschka for more information.
Phone: 415-476-3229
Web: http://clinicaltrials.gov/ct2/show/NCT00135694
Email: Hepatitis C-Gradual Withdrawal of Immune System Supressing Drugs in Patients Receiving a Liver Transplant
Hepatitis C-Study of Nitazoxanide with Peginteferon and Ribivirin in people with Hepatitis C who have never been treated
Stanford University School of Medicine - (Directions)
300 Pasteur Dr.
Stanford, CA 94305
Principle Investigators: Aijaz Ahmed, MD
Walid Ayoub, MD
This study is ongoing, but is not recruiting participants.
Contact Shawna Thunen for more information.
Phone: 650-723-5512
Hepatitis C: A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1
University of California, San Francisco
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
Recruitment Period: Open
Principal Investigator: Paula Lum, MD, MPH
Contact: Jamye Ford, M.A. 415-476-4082, jford@php.ucsf.edu
Hepatitis C: Phase ib Study of Omega DUROS in Patients with Chronic Hepatitis C Who Relapsed Prior to Treatment
California Pacific Medical Center
San Francisco, CA
Principal Investigator-Natalie Bzowej, MD
This study is ongoing, but is not recruiting participants
Contact Alex Ryvkin, RN for more information.
Phone: 415-600-1158
Hepatitis C: Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Stanford University School of Medicine
300 Pasteur Dr.
Stanford, CA 94305
The purpose of this study is to determine if nitazoxanide in combination with peginterferon alfa-2a and ribavirin is safe and effective in treating chronic hepatitis C in patients that have previously failed to respond to treatment with peginterferon and ribavirin.
Principle Investigator: Aijaz Ahmed, M.D.
Contact Shawna Thunen for more information.
Phone: 650-723-5512
HepatitisB-A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
University of California, San Francisco
San Francisco, CA
Principle Investigator: Philip Rosenthal
Study sponsor: Bristol Myers Squibb
Study ID Numbers: AI463-028
Recruitment Period: OPEN
Hepatocellular Carcinoma
California Pacific Medical Center - (Directions)
2324 Sacramento Street
San Francisco, CA 94115
Protocol Title:
Phase III randomized, placebo controlled, double-blind trial of sorafenib plys erlotinib vs. sorafenib plus placebo as first line systematic treatement for hepatocellular carcinoma.
Recruitment Period:
OPEN
Principal Investigator:
Ari Baron, MD
Contact Anna Ruiz for more information.
Phone: 415-600-3214
Web: http://www.cpmc.org/professionals/research/trials/oncologylivercancer.html
Email: Hepatocellular Carcinoma
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford University School of Medicine
Description: The objective of the study is to identify novel blood markers for the diagnosis of liver cancer. We will collect serum samples from consented patients and measure the levels of potential protein markers in their serum.
Inclusion Criteria: For inclusion criteria, please visit the website listed.
Investigator: Samuel So
Contact Mei-Sze Chua for more information.
Phone: 650-724-3525
Email: Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Liver Cancer-Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery
University of California, Davis
Recruitment Period: OPEN
LOCATION 1: Contra Costa Regional Medical Center; Contact Sharon Hiner 925-370-5114 shiner@hsd.co.contra-costa.ca.us
LOCATION 2: Veterans Affairs Outpatients Clinics, Martinez, CA; Contact Ted Wun, MD 925-372-2062
LOCATION 3: UC Davis Medical Center, Davis, CA
Phone: 916-734-3089
Liver Cancer-Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford University School of Medicine
300 Pasteur Dr.
Stanford, CA 94305
The aim of this study is to identify new blood markers of liver cancer that can be used to increase the rate of accurate diagnosis of this malignancy.
Principle Investigator: Samuel So, MD
Contact Mei-Sze Chua for more information.
Phone: 650-724-3525
Email: Liver Cancer-Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
California Pacific Medical Center
Protocol Title: A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of Once-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects with Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
Patient Population: Subjects who have thrombocytopenia related to chronic liver disease and are scheduled to undergo an elective surgical or diagnostic procedure.
Principal Investigator: Maurizio Bonacini, MD
Contact Catherine Carr for more information.
Phone: 415-600-1369
Web: http://www.cpmc.org/professionals/research/trials/heplisting.html
Email: Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
Pediatric Liver Transplantation, Failure-Trials w/ UCSF
University of California, San Francisco
San Francisco, CA
- Non-Alcoholic Steatohepatitis Study (NASH) sponsored by the National Institutes of Health (NIH) Not yet open for enrollment Age 8-15 years at first screening visit - Histologic evidence of Nonalcoholic Fatty Liver Disease (NAFLD) - ALT level >1.5 times the upper limit of normal within two weeks of randomization and within the prior 6 months - Willingness to avoid pregnancy through abstinence or effective birth control methods - Consent
- Pediatric Non Acetylcysteine (NAC) for Acute Liver Failure Study (NAC for ALF) sponsored by the National Institutes of Health (NIH)
- Liver Transplantation in HIV + Children sponsored by the National Institues of Health (NIH) National Institute Allergy and Infectious Disease
Contact Danusia Filipowski for more information.
Phone: (415) 476-1756
Web: http://www.pediatrics.medschool.ucsf.edu/gi/research/studies/index.aspx#hepatologytrials
Email: Pediatric Liver Transplantation, Failure-Trials w/ UCSF
PII Combination SBRT with TACE for Uresectable Hepatocellular Carcinoma
Stanford University School of Medicine
Description: To establish the efficacy and toxicity of TACE combined with SBRT
Inclusion Criteria: For inclusion criteria, please visit the website listed
Investigators: Daniel Chang, Cheryl Cho-Phan; Goerge Fisher MD PhD, James Ford, Dr. Lawrence (Rusty) Hoffman MD, Aya Kamaya, Albert Koong, Samuel So, Daniel Yng-Ho Sze, Brendan C Visser
Contact Laurie Ann Columbo for more information.
Phone: (650) 736-0792
Web: http://med.stanford.edu/clinicaltrials/publicCancerDisplayDetails.do?studyId=3882&age=adul
Email: PII Combination SBRT with TACE for Uresectable Hepatocellular Carcinoma
Primary Biliary Cirrhosis: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
University of California, Davis
The purpose of this study is to determine the safety of the anti-CD20 antibody rituximab in treating patients with Primary Biliary Cirrhosis (PBC). Rituximab is a laboratory-made antibody currently used to treat some kinds of lymphoma. Rituximab may also help people with PBC, a disease of the immune system. However, the safety of rituximab in PBC patients must first be established.
Principal Investigator: Eric Gershwin, MD
Clinicaltrials.gov Identifier: NCT00364819
Contact Marilyn Robinson for more information.
Phone: 916-703-5501
Email: Primary Biliary Cirrhosis: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
Sex Hormone Levels and Intrapulmonary Shunting in Patients with Liver Disease
California Pacific Medical Center
Patient Population: Subjects with a known or suspected diagnosis of NAFLD, either simple steatosis, NASH or NASH-Related cirrhosis or cryptogenic cirrhosis
Principal Investigator: Raphael Merriman, MD
Contact Julie Gillespie Payne, MD for more information.
Phone: 415-600-3891
Web: http://www.cpmc.org/professionals/research/trials/heplisting.html
Email: Sex Hormone Levels and Intrapulmonary Shunting in Patients with Liver Disease
Stanford Cancer Clinical Trials Information Line
Stanford Cancer Center
The Stanford Cancer Clinical Trials Information Line directs callers to current cancer clinical studies at Stanford and related resources. A recruitment specialist points patients to studies for which they may be eligible and connects them to study coordinators prior to an in-person consultation with a physician. Before acceptance into a study, patients receive an explanation of potential benefits and risks of trial participation.
Some clinical trials are only for newly diagnosed cancers. It is important to inquire about the availability of clinical trials before starting treatment.
Phone: 650-498-7061
Web: cancer.stanford.edu/trials
Email: Stanford Cancer Clinical Trials Information Line
Temsirolimus and Bevacizumab in Treating Petients with Locally Advanced Recurrent, Metastatic or Progressive Liver Cancer
UC Davis Medical Center
Description: This phase II trial is studying the side effects of giving temsirolimus together with bevacizumab and to see how well it works in treating patients with locally advanced, recurrent, metastatic, or progressive endometrial cancer, ovarian epithelial cancer, liver cancer, islet cell cancer, or carcinoid tumor.
Investigator: David Gandara
Phone: (916) 734-8452
Transplant- Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
University of California, San Francisco
Title: A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
The purpose of this study is to determine whether a slow withdrawal of immune system-suppressing medications is safe. The study will also look at whether slow withdrawal will help reduce the long-term side effects of immune system-suppressing medications and decrease the chance for HCV infection of the new liver in transplant patients with HCV.
Principle Investigator: Sandy Feng, MD
Contact Sharon Blaschka for more information.
Phone: 415-476-3229
Email: Transplant- Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Transplant-Kidney and Liver Transplantation in People with HIV
University of California, San Francisco
San Francisco, CA
With improved anti-HIV drug therapy, HIV infected patients are now living longer. These patients are at risk for liver and kidney failure and may need organ transplants. However, little is know about the safety and effectiveness of organ transplants in patients with HIV. This study will evaluate organ transplantation in HIV infected patients undergoing liver and kidney transplants.
Study Design: Cohort, Prospective
Official Title: Solid Organ Transplantation in HIV: Multi-Site Study
Eligibility: 1 year and older
Principal Investigators-Michelle Stock, MD, Michelle Roland, MD Contact Laurie Carlson: carlsonl@surgery.ucsf.edu
Contact Laurie Carlson or Annette Klemme for more information.
Phone: 415-353-8892 (415-353-8592)
Transplant: Evaluation of Belatacept as First Line Immunosuppression in De Novo Liver Transplant Recipients
University of California, San Francisco
San Francisco, CA
The purpose of this clinical research study is to evaluate the effects of belatacept, relative to tacrolimus, on the incidence of rejection, graft loss and death in subjects receiving a liver transplant
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Ages Eligible for Study: 18 Years - 70 Years
Principle Investigator-Sandy Feng, MD, Ph.D
This study is ACTIVE, but CLOSED FOR ENROLLMENT
Transplant: Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients
University of California, San Francisco
San Francisco, CA
Principal Investigator-Peter Chin-Hong, MD
This study is ongoing, but is not recruiting participants
Contact John Lough for more information.
Phone: 415-476-4862
Use of TheraSphere for Unresectable Hepatocellular Carcinoma
Stanford University School of Medicine
Description: To provide Therasphere treatement for patients diagnosed with unresectable liver cancer.
Inclusion Criteria: Patients over 18 years of any race, sex, who have hepatocellular carcinoma of the liver, and who are able to give informed consent; Must have an ECOG Performance Status score of £ 2 with a life expectancy of > = 3 months, non-pregnant with an acceptable contraception in premenopausal women; Must be >4 weeks since prior radiation or prior surgery and at least 1 month post other chemotherapy
Investigators: Daniel Yung-Ho Sze, Dr. Lawrence (Rusty) Hoffman MD
Contact Shyam Panchal for more information.
Phone: (650) 725-9810
Web: http://med.stanford.edu/clinicaltrials/publicCancerDisplayDetails.do?studyId=4802&age=adul
Email: Use of TheraSphere for Unresectable Hepatocellular Carcinoma
American Organ Transplant Association
For information on transportation costs and fundraising, call 713.261.2682
Web: http://aotaonline.org/
Angel Flights America
- (Directions)
3161 Donald Douglas Loop South
Santa Monica, CA 90405
Angel Flights volunteer pilots provide free air transportation to and from scheduled medical treatment within a 300 mile radius. Requests can be filed by a doctor's office, nurse, case manager, or social worker.
Phone: 888.426.2643
Web: http://www.angelflightwest.org/
Email: Angel Flights America
Children's OrganTransplant Association
For help with organizing local fundrasing, call 812.489.3863
Phone: 800.366.2682
Web: www.cota.org
Email: Children's OrganTransplant Association
National Foundation for Transplants
Offers fundraising assistance for organ and tissue transplant patients.
Phone: 800.489.3863
Web: http://transplants.org/
National Transplant Assistance Fund
The mission of NTAF is to help transplant and catastrophic injury patients afford critical but uninsured medically related expenses through fundraising guidance, patient support and resources, as well as financial assistance.
Phone: 800.642.8399
Web: http://www.transplantfund.org/
The Transplant Foundation
Grants for immunosupressive drug users: 804.285.5115
Phone: 866.900.3172
Web: http://www.transplantfoundation.org/
Transplant Centers serving Northern CA & Nevada
University of California, San Francisco Medical Center
Liver Transplant Program
505 Parnassus Avenue San Francisco, CA 94122
415-353-1888
Liver Clinic
505 Parnassus Avenue San Francisco, CA 94122
415-353-2318
California Pacific Medical Center
Liver Disease Management & Transplant Program
2340 Clay Street, 2nd FloorSan Francisco, CA 94115
415-600-1001
Stanford Hospital
Liver Transplant Clinic
300 Pasteur Drive, A100 Stanford, CA 94305
650-723-6961
Liver Clinic
300 Pasteur Drive
Stanford, CA
(650) 723-6961
University of California, Davis Medical Center
Transplant Center
2315 Stockton Blvd. Sacramento, CA 95817
916-734-2111
800-821-9912
San Francisco Bay Area Chapter:
Transplant Recipients International Organization (TRIO)
TRIO National Office: 800.TRIO.386
Phone: 408.446.0565 (408.446.0565)
Web: http://www.trioweb.org/
United Network of Organ Sharing (UNOS)
Phone: 800.24.DONOR
Web: http://www.unos.org/
Angel Flight West
Santa Monica, California - (Directions)
3161 Donald Douglas Loop South
Santa Monica, CA 90405
The mission of Angel Flight West is to arrange free air transportation on private aircraft in response to health care and other compelling human needs. Angel Flight West links volunteer private pilots with needy people whose non-emergency health care problems require travel to and from medical facilities throughout the thirteen western states. Angel flight West pilots donate the cost of all flights. There is never a charge for an Angel flight mission.
Phone: (888) 4-AN-ANGEL ((310) 390-2958)
Web: www.angelflightwest.org
Email: Angel Flight West
California Hepatitis Alliance (CalHep)
The California Hepatitis Alliance (CalHEP) seeks to reduce the scope and consequences of the
hepatitis B and C epidemics, which disproportionately affect California's ethnic communities
and the social-economically underserved.
Web: www.calHEP.org
California Uninsured Help Line
Help finding no-cost and low-cost health care for individuals, families, and small businesses
Phone: 1-800-234-1317
CenterWatch
CenterWatch is a company dedicated to providing patients and their advocates with a variety of information services and educational materials on clinical research. Their Web site - www.centerwatch.com - provides an extensive list of IRB approved clinical trials being conducted internationally. Many of these trials may be appropriate for your participation. The Web site also lists promising therapies newly approved by the FDA (Food and Drug Administration).
Web: www.centerwatch.com/
Children's Liver Association for Support Services
California - (Directions)
25379 Wayne Mills Place Suite 143
Valencia, CA 91355
Children's Liver Association for Support Services (C.L.A.S.S.) in an online support group. It is an all volunteer group, and was formed because of the recognized need for an organization dedicated to addressing the emotional, educational and financial needs of families with children affected by liver disease and transplantation.
Phone: 1-877-679-8256 (661-263-9099)
Web: www.classkids.org
Doc Misha's Chicken Soup Chinese Medicine
Information on Eastern treatment and healing approaches by Misha Ruth Cohen, O.M.D., L.Ac. Features include an overview of Chinese medicine, HIV Wellness, and a Hepatitis Help Section.
Web: www.docmisha.com
HCV Advocate
HCV Advocate is a website dedicated to informing people about hepatitis B&C. The website includes news updates, community and support groups and a resource library.
Web: www.hcvadvocate.org
Health Consumer Alliance
Health Consumer Alliance is a partnership of consumer assistance programs operated by community-based legal services organizations. Their goal is to help low-income people obtain essential health care. Visit healthconsumer.org to find your local center in the following CA counties:
- Alameda
- El Dorado
- Fresno
- Imperial Valley
- Kern
- Los Angeles
- Orange
- Placer
- Sacramento
- San Diego
- San Francisco
- San Mateo
- Yolo
Web: healthconsumer.org
Hepatitis B: Public Testing & Vaccination Sites in San Francisco
San Francisco Hep B Free is a citywide campaign to turn San Francisco into the first hepatitis B free city in the nation. This unprecedented 2-year-long campaign will screen, vaccinate and treat all San Francisco Asian and Pacific Islander (API) residents of hepatitis B (HBV) by providing convenient, free or low-cost testing opportunities at partnering health facilities and events.
Testing and Vaccination Sites
AITC (Adult Immunization & Travel Clinic)
101 Grove Street, #102
415-554-2625
Asian Pacific Wellness Center
730 Polk Street, 4th floor
415-292-3400
Call for appointment
Chinese Hospital
845 Jackson Street
1st Floor, Laboratory
415-677-2303
Excelsior Health Services
888 Paris Street
415-677-2488
SFDPH Chinatown Public Health Center
UCSF Hepatitis B Collaborative
1490 Mason Street
415-364-7910
Sunset Health Services
1800 31st Avenue
415-677-2388
UCSF Medical Center at Mt. Zion
2300 Post Street, 1st floor
415-885-3580
Web: www.sfhepbfree.org
Hepatitis C Meditations
Self-Care for Hepatitis C ~ Applied Meditation for a Healthy Liver is a one-of-a-kind program designed to address the challenges of hepatitis C and empower you to deal with them successfully. This unique audio CD and booklet set is designed to promote liver health, and can be helpful with all the liver diseases. Download a free seven-minute meditation: Seven Minutes for Liver Health.
Web: www.hepcmeditations.org
National Center for Complementary and Alternative Medicine (NCCAM)
National Institutes of Health - (Directions)
NCCAM Clearinghouse P.O. Box 7923
Gaithersburg, MD 20898
Sponsored by the National Institutes of Health, NCCAM contains databases and research on alternative therapies including: Acupuncture, Echinacea, Evening Primrose Oil, Herbs at a Glance, Milk Thistle, St. John's Wort. NCCAM does not provide medical advice or referrals to practitioners. Decisions about medical care and treatment should be made in consultation with a health care provider, based on the condition and needs of each person. Please visit NCCAM's website for more information.
Phone: 1-888-644-6226
Web: www.nccam.nih.gov
Email: National Center for Complementary and Alternative Medicine (NCCAM)
National Digestive Diseases Information Clearinghouse
The National Digestive Diseases Information Clearinghouse (NDDIC) is an information dissemination service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services.
Web: digestive.niddk.nih.gov
National Immunization Hotline
General information on immunizations, updated schedules, and guidlines.
Phone: 1-800-232-4636 (English/Spanish) (1-888-232-6348 (TTY))
Web: www.cdc.gov/vaccines
National Immunization Hotline
General information on vaccinations, updated schedules and guidelines.
Phone: 1-800-232-4636 (English/Spanish) (1-888-232-6348 (TTY))
Web: www.cdc.gov/vaccines/
Office of the Patient Advocate
- (Directions)
980 9th Street
Suite 500
Sacramento, CA 95814
The Office of the Patient Advocate (OPA) is an independent office in state government charged with informing and educating consumers about their rights and responsibilities as HMO enrollees. Established in July 2000, OPA is required to annually publish an internet-based HMO Report Card on the quality of HMO services, develop consumer education materials and programs, assist HMO enrollees, advise the Department of Managed Health Care regarding consumer issues, and collaborate with government and community-based patient advocacy organizations.
Phone: 916-324-6407
Web: www.opa.ca.gov
Partnership for Prescription Assistance
The Partnership for Prescription Assistance brings together America’s pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that’s right for them. Many will get them free or nearly free. Its mission is to increase awareness of patient assistance programs and boost enrollment of those who are eligible. Through this site, the Partnership for Prescription Assistance offers a single point of access to morke than 475 public and private patient assistance programs, including more than 150 programs offered by pharmaceutical companies. To access the Partnership for Prescription Assistance by phone, you can call toll-free, 1-888-4PPA-NOW (1-888-477-2669).
The PPA program also provides information on co-payment programs, savings cards and information on more than 10,000 free health care clinics in America -- connecting more than 277,000 patients with clinics and health care providers in their communities.
Phone: 1-888-4PPA-NOW (1-888-477-2669)
Web: www.pparx.org
PEGASSIST
A comprehensive patient education and support program for those on PEGASYS® (Peginterferon alfa-2a) therapy. Included on the website are videos and helpful guides that you can download. Also visit the site for tips on how to take PEGASYS, tips for getting over needle anxiety, coping with side effects, or tips for getting the support you need from your doctors, family, and friends.
There is also 24/7 Nurse Support available for patients that need help with injections or would like knowledgeable advice about side effects. Call 1-877-734-2797.
Phone: 1-877-PEGASYS (1-877-734-2797)
Web: www.pegassist.com
Pfizer MAINTAIN™ Program
In an effort to help recently unemployed Americans, Pfizer has developed "Medicines Assistance for Those Who are in Need (MAINTAIN)." To learn more about the MAINTAIN program and how it can help individuals in your community, please visit www.PfizerHelpfulAnswers.com.
Phone: 1-866-706-2400
Web: www.PfizerHelpfulAnswers.com
RxHelpForCalifornians
California
RxHelpForCalifornians is a program that connects qualified, low-income people with discount prescription drugs, direct from the pharmaceutical manufacturer.
RxHelpForCalifornians offers a single point of access to public and private patient assistance programs, including more than 150 programs offered by pharmaceutical companies.
RxHelpForCalifornians helps low-income, uninsured patients:
- Enroll in more than 150 company patient assistance programs
- Access more than 1,200 medicines for free or at a low cost
- Learn how to contact government programs for which they may qualify, such as Medicaid, Medicare, or the State Children’s Health Insurance Program
Visit www.rxhelpforca.org/ for more information
Phone: 877-777-7815
Web: www.rxhelpforca.org
Sierra Health ResourcesHepatitis Testing
Angels Camp, CA - (Directions)
1168 Booster Way
Angels Camp, CA 95222
Sierra HOPE provides free Hepatitis Testing, and serves Amador, Tuolumne and Calaveras Counties. Please call first for an appoinment and more information.
Phone: 209-736-6792
Web: http://www.sierrahope.org/page5.html
United Way: Bay Area
All health and human service assistance
Phone: 808.4300 or 211
Print
del.icio.us